Method and Device for Utilizing Analyte Levels to Assist in the Treatment of Diabetes
2 Assignments
0 Petitions
Accused Products
Abstract
A health-monitoring device assesses the health of a user based on levels of two analytes in a biological fluid. A first analyte that is utilized to assess a user'"'"'s health is a fat metabolism analyte, such as ketones, free fatty acids and glycerol, which is indicative of fat metabolism. A second analyte that is utilized is a glucose metabolism analyte, such as glucose. The levels of the two analytes may be used to assess insulin sensitivity, to detect both recent hypoglycemia and the cause of high glucose levels, and/or to guide therapeutic intervention. The dual analyte model may calculate a discrepancy between an actual insulin activity level and a theoretical insulin activity level. The dual analyte model of the present invention may be used to identify individuals at risk for metabolic syndrome, insulin resistance and non-insulin dependent diabetes, and allows monitoring of the progression of those disease states, as well as progress made by therapeutic interventions.
-
Citations
99 Claims
-
1-20. -20. (canceled)
-
21. A health-monitoring device for use in treating Type II diabetes, comprising:
-
a housing; a test port in communication with the housing, wherein the test port is configured to receive a test element; a processor in communication with the housing and configured to receive one or more signals associated with an analyte sample received at the test port; a storage unit in communication with the housing and configured to store one or more programs executable by the processor for determining a dosage information for long acting insulin based at least in part on the one or more signals associated with the analyte sample; a display coupled to the housing and configured to provide graphic representations and/or text summaries of output data associated with the one or more signals associated with an analyte sample and/or the determined dosage information for long acting insulin; and a data communication port operatively coupled to the processor. - View Dependent Claims (22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59)
-
-
60. A system for use in treating Type II diabetes, comprising:
-
a health monitoring device, comprising; a housing; a test port in communication with the housing, wherein the test port is configured to receive a test element; a processor in communication with the housing and configured to receive one or more signals associated with an analyte sample received at the test port; a storage unit in communication with the housing and configured to store one or more programs executable by the processor for determining a dosage information for long acting insulin based at least in part on the one or more signals associated with the analyte sample; a display coupled to the housing and configured to provide graphic representations and/or text summaries of output data associated with the one or more signals associated with an analyte sample and/or the dosage information for long acting insulin; and a data communication port operatively coupled to the processor; an injection pen; and long acting insulin. - View Dependent Claims (61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97)
-
-
98. A health-monitoring device for use in treating diabetes with injections, comprising:
-
a housing; a test port in communication with the housing, wherein the test port is configured to receive a test element; a processor in communication with the housing and configured to receive one or more signals associated with an analyte sample received at the test port; a storage unit in communication with the housing and configured to store one or more programs executable by the processor for determining a dosage information for long acting insulin based at least in part on the one or more signals associated with the analyte sample; a display coupled to the housing and configured to provide graphic representations and/or text summaries of output data associated with the one or more signals associated with an analyte sample and/or the determined dosage information for long acting insulin; and a communication port operatively coupled to the processor. - View Dependent Claims (99)
-
Specification